Digital Restriction Enzyme Analysis of Methylation (DREAM).

Area of Science:

• Genomics
• Epigenetics
• Molecular Biology

Background:

• DNA methylation is a critical epigenetic modification influencing gene expression.
• Accurate and quantitative mapping of DNA methylation is essential for understanding various biological processes and diseases.
• Existing methods like bisulfite sequencing have limitations including harsh chemical treatments and potential for DNA damage.

Purpose of the Study:

• To introduce and validate Digital Restriction Enzyme Analysis of Methylation (DREAM) as a novel method for quantitative DNA methylation mapping.
• To demonstrate the advantages of DREAM over traditional methods, such as avoiding bisulfite conversion.

Main Methods:

• DREAM utilizes sequential digestion of genomic DNA with SmaI and XmaI restriction enzymes at CCCGGG sites.
• Methylation-specific signatures (5'-GGG for unmethylated, 5'-CCGGG for methylated CpG sites) are generated.
• DNA fragments are adapter-ligated, barcoded, pooled, and sequenced using next-generation sequencing (NGS).
• Methylation levels are calculated by analyzing sequencing reads mapped to CpG sites.

Main Results:

• DREAM provides quantitative DNA methylation levels with high sensitivity and low background.
• The method is highly reproducible and cost-effective, requiring minimal DNA input.
• Sequencing 25 million reads typically covers 50,000 unique CpG sites with hundreds of reads for accurate quantification.

Conclusions:

• DREAM is a robust, simple, and cost-effective method for quantitative genome-wide DNA methylation analysis.
• It offers a valuable alternative to bisulfite conversion, suitable for any species.
• DREAM enables accurate determination of DNA methylation levels without the need for harsh chemical treatments.